retatrutide mechanism of action triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof concept Retatrutide Dosage & Titration: Complete
Description
doi: 10.1093/ajcn/77.3.605
In ovarian granulosa cells, hypermethylation of the steroidogenic enzyme cytochrome P450 family 19 subfamily A member 1 (CYP19A1) promoter reduces estrogen biosynthesis while relatively increasing androgen production, thereby exacerbating hyperandrogenemia (52)
Summary The GLP-1 drug market is rapidly expanding, driving strong enthusiasm among companies for GLP-1 drug development
Gordon A, Dixit K, Shachi T, Salonia J, Seltzer E
ME-T: Methodology, Visualization, Formal Analysis, Investigation, Writing original draft, Writing review and editing
